Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
Merlo A, Turrini R, Bobisse S, Zamarchi R, Alaggio R, Dolcetti R, Mautner J, Zanovello P, Amadori A, Rosato A.
Merlo A, et al. Among authors: dolcetti r.
J Immunol. 2010 May 15;184(10):5895-902. doi: 10.4049/jimmunol.0902850. Epub 2010 Apr 12.
J Immunol. 2010.
PMID: 20385879